SomaLogic to Participate in the Cowen 42nd Annual Health Care Conference

BOULDER, Colo., Feb. 25, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the Cowen 42nd Annual Health Care Conference.

SomaLogic management is scheduled to participate in a fireside chat on Wednesday, March 9, 2022, at 11:10 a.m. Eastern Time. Interested parties may access a live and archived webcast of the virtual session on the “Investors” section of the company’s website at: https://investors.somalogic.com/events-and-presentations.

About SomaLogicSomaLogic (Nasdaq: SLGC) seeks to deliver precise, meaningful, and actionable health-management information that empowers individuals worldwide to continuously optimize their personal health and wellness throughout their lives. This essential information, to be provided through a global network of partners and users, is derived from SomaLogic’s personalized measurement of important changes in an individual’s proteins over time. For more information, visit www.somalogic.com and follow @somalogic on Twitter.

The SomaScan Platform is for Research Use Only (RUO) and has not been cleared or approved by the U.S. Food and Drug Administration for diagnostic or patient management purposes.

SomaLogic Contact        Emilia Costales720-798-5054[email protected]

Investor ContactMarissa Bych Gilmartin Group LLC[email protected]

You May Also Be Interested In

• 2026 Global Open-source AI Challenge Grand Finals and Awards Ceremony Held in Hangzhou
• Solana Price Today: SOL ETFs Post 12 Straight Weeks of Inflows While Pepeto Eyes
• Velox Pickleball Expands Wholesale Program to Meet Growing Retail Demand for Premium Paddles